title: Early HCC treatment: a future strategy against interferon/miR-484 axis to revert precancerous lesions?
authors.affiliation: Department of Internal Medicine I, Ulm University, Ulm, Germany.
authors.forename: André
authors.initials: A
authors.lastname: Lechel
authors.affiliation: Inserm, U1016, Institut Cochin, Paris, France Cnrs, UMR8104, Paris, France Université Paris Descartes, Sorbonne Paris Cité, Paris, France Equipe labellisée LNCC, Paris, France.
authors.forename: Angélique
authors.initials: A
authors.lastname: Gougelet
mesh_terms: D000998:Antiviral Agents; D006528:Carcinoma, Hepatocellular; D045744:Cell Line, Tumor; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007372:Interferons; D008113:Liver Neoplasms; D035683:MicroRNAs
chemical_list: D000998:Antiviral Agents; D035683:MicroRNAs; D007372:Interferons
keywords: HEPATOCELLULAR CARCINOMA; INFLAMMATORY MEDIATORS